Johnson & Johnson - stock earnings
JNJ Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2020Q3 | 3.6 billion USD | 21.1 billion USD |
| 2021Q1 | 1.7 billion USD | 22.5 billion USD |
| 2021Q2 | 6.2 billion USD | 22.3 billion USD |
| 2021Q3 | 6.3 billion USD | 23.3 billion USD |
| 2021Q4 | 3.7 billion USD | 23.3 billion USD |
JNJ Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2017 | 1.3 billion USD | 76.5 billion USD |
| 2018 | 15.3 billion USD | 81.6 billion USD |
| 2019 | 15.1 billion USD | 82.1 billion USD |
| 2021 | 14.7 billion USD | 82.6 billion USD |
JNJ
List: Champions
Price: 157.62USD
Dividend Yield: 2.49%
Forward Dividend Yield: 2.64%
Payout Ratio: 63.76%
Dividend Per Share: 4.24 USD
Earnings Per Share: 10.42 USD
P/E Ratio: 28.84
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers—General
Volume: 5.4 million
Ebitda: 2.9 billionMarket Capitalization: 430.0 billion
Average Dividend Frequency: 4
Years Paying Dividends: 60
DGR3: 6.23%
DGR5: 6.17%
DGR10: 6.55%
DGR20: 9.81%